Compounding pharmaceuticals
2026 · 2nd Quarter (Apr 1 - June 30)
BELCHER PHARMACEUTICALS LLC
Filed by TSG ADVOCATES DC, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- TSG ADVOCATES DC, LLC
- Filing UUID
- 4113d957-c137-49ed-b3f5-9b98a941af34
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Compounding pharmaceuticals
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.